Celltrion Celebrates Interchangeability Designation For Humira Biosimilar In The US
Also, Biosimilar Approvals In Australia And Supply Bids In Latin America
Celltrion’s adalimumab biosimilar was crowned as interchangeable by the FDA, at a time when the future of the designation is unknown.
